Bickley, United Kingdom

Vir Vijay Kakkar

This inventor holds 3 USPTO granted patents. Top assignee: Trigen Gmbh. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vir Vijay Kakkar. Retrieved from https://idiyas.com/inventor/vir-vijay-kakkar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Vir Vijay Kakkar

Introduction

Vir Vijay Kakkar is a notable inventor based in Bickley, GB. He has made significant contributions to the field of biotechnology, particularly in the development of peptide analogues that have potential applications in cell growth and chemotaxis.

Latest Patents

Kakkar holds three patents, with his latest inventions focusing on platelet-derived growth factor analogues. One of his patents involves novel peptide analogues of platelet-derived growth factor, which are designed to inhibit or stimulate the growth and/or chemotaxis of cells, such as smooth muscle cells. Additionally, he has developed cyclic platelet-derived growth factor analogues and pharmaceutical compositions that utilize these innovations.

Career Highlights

Kakkar is currently associated with Trigen GmbH, where he continues to advance his research and development efforts in the field of biotechnology. His work has the potential to impact various medical applications, particularly in regenerative medicine.

Collaborations

Some of his notable coworkers include Geeta Patel and Yemisi Olabiran, who contribute to the collaborative efforts at Trigen GmbH.

Conclusion

Vir Vijay Kakkar's innovative work in peptide analogues and growth factors showcases his commitment to advancing biotechnology. His contributions are paving the way for new therapeutic approaches in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…